Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,832 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.
Loras C, Gisbert JP, Mínguez M, Merino O, Bujanda L, Saro C, Domenech E, Barrio J, Andreu M, Ordás I, Vida L, Bastida G, González-Huix F, Piqueras M, Ginard D, Calvet X, Gutiérrez A, Abad A, Torres M, Panés J, Chaparro M, Pascual I, Rodriguez-Carballeira M, Fernández-Bañares F, Viver JM, Esteve M; REPENTINA study; GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) Group. Loras C, et al. Among authors: torres m. Gut. 2010 Oct;59(10):1340-6. doi: 10.1136/gut.2010.208413. Epub 2010 Jun 24. Gut. 2010. PMID: 20577000
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Loras C, Saro C, Gonzalez-Huix F, Mínguez M, Merino O, Gisbert JP, Barrio J, Bernal A, Gutiérrez A, Piqueras M, Calvet X, Andreu M, Abad A, Ginard D, Bujanda L, Panés J, Torres M, Fernández-Bañares F, Viver JM, Esteve M; GETECCu (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa). Loras C, et al. Among authors: torres m. Am J Gastroenterol. 2009 Jan;104(1):57-63. doi: 10.1038/ajg.2008.4. Am J Gastroenterol. 2009. PMID: 19098850
Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.
Sánchez-Tapias JM, Forns X, Ampurdanés S, Titó L, Planas R, Viver JM, Acero D, Torres M, Mas P, Morillas R, Forné M, Espinós J, Llovet JM, Costa J, Olmedo E, López-Labrador FX, Jiménez de Anta MT, Rodés J. Sánchez-Tapias JM, et al. Among authors: torres m. Gut. 1996 Apr;38(4):603-9. doi: 10.1136/gut.38.4.603. Gut. 1996. PMID: 8707096 Free PMC article. Clinical Trial.
Lobular panniculitis associated with ciprofloxacin.
Rodríguez E, Martínez JA, Torres M, Nubiola A, Buges J. Rodríguez E, et al. Among authors: torres m. BMJ. 1990 Jun 2;300(6737):1468. doi: 10.1136/bmj.300.6737.1468-b. BMJ. 1990. PMID: 2379015 Free PMC article. No abstract available.
3,832 results